ALKS

🏥 Healthcare

Alkermes plc

Conservative #43Aggressive #447Low Risk

$31.91-0.28%

Day High$31.99

Day Low$31.40

Volume1.8M

Mkt Cap$5.3B

52W Low $2552W High $36

Market Cap

$5.5B

P/E Ratio

16.5

Sector avg: 19.1

Rev Growth

-6.4%

Sector avg: 8.0%

Earnings Growth

-28.3%

Profit Margin

23.9%

Sector avg: 16.9%

Debt/Equity

0.05

Score Breakdown

Overall Score80.0

Fundamental Score78.5

ML Score85.4

Score by Horizon

3 Month

71.7

6 Month

80.1

Primary

1 Year

84.3

Quality Assessment

Earnings Grade

Strong fundamentals, high earnings quality

Position Sizing

Suggested Allocation

Confidence

high

Analysis Signals

Positive Signals

Fundamental: 78.5 (sector-relative)

ML percentile=85.4 (pre-ranked by batch)

Procyclicality dampener: ML weight reduced to 9.0% (S&P 500 return=25.0% > 20% (extended rally); Yield curve inverted (-10bp) — recession signal; Late-cycle score 2/3 → ML weight ×0.90)

Blend: 91% fund (78.5) + 9% ML (85.4) = 79.2

Market-cap adj: +0.5pt ($5.5B)

Risk Signals

Risk (low): Low vol 8.7% → +5.1pt; Drawdown 20% → -4.7pt

Sector Peer Comparison(Healthcare — 11 stocks in universe)

Stock	Score	P/E	Rev Growth	Margin	Mkt Cap
ALKSAlkermes plc	80.0	16.5	-6.4%	23.9%	$5.5B
GMABGenmab A/S	90.3	13.1	22.8%	36.4%	$18.5B
EXELExelixis, Inc.	83.5	15.1	7.0%	33.7%	$11.7B
SNYSanofi	83.4	9.1	5.5%	18.2%	$113.6B
NBIXNeurocrine Biosciences, Inc.	81.1	26.5	21.4%	16.7%	$12.5B
GEHCGE HealthCare Technologies Inc.	80.5	17.7	4.8%	10.1%	$36.6B
Sector Average	79.0	19.1	8.0%	16.9%	—

Why This Stock

HealthcareReasonable P/EHealthy profit marginHigh quality

Scores are generated by a multi-stage ML pipeline combining fundamental analysis, ensemble predictions, and structural risk signals. All data is for research purposes only and does not constitute financial advice. Past performance does not guarantee future results.